Method for defining signal templates in implantable cardiac devices

• US 7,991,459 B2
• Filed: 11/16/2007
• Issued: 08/02/2011
• Est. Priority Date: 11/29/2004
• Status: Active Grant

• Current Assignee: Cameron Incorporated (Schlumberger NV)
• Original Assignee: Cameron Incorporated (Schlumberger NV)
• Inventors: Ostroff, Alan H., Warren, Jay A., Palreddy, Surekha
• Primary Examiner(s): Bockelman; Mark W
• Assistant Examiner(s): So; Elizabeth K
• Application Number:
  US11/941,781
• Publication Number:
  US 20080119748A1
• Time in Patent Office: 1,355 Days
• Field of Search: 600/509, 600/516
• US Class Current: 600/516
• CPC Class Codes: A61B 5/35 by template matching
• CPC Class Codes: A61B 5/366 Detecting abnormal QRS complex, e.g. widening

Abstract

Template formation methods for use in implantable cardiac rhythm management devices. In an illustrative method, a signal is captured in an implanted cardiac rhythm management device, and parameters for analysis of the captured signal are then defined. Then, in the example, additional signals can be captured and used to either verify or discard the captured signal defined parameters. The template formation methods provide for creating a robust template to compare with sensed cardiac complexes. Devices and systems configured to perform template formation and verification methods are also shown.

Claims

1. A method of generating a template for use in morphology analysis of cardiac activity, as represented by electric signals, in an implantable medical device, the implantable medical device comprising a plurality of implantable electrodes coupled to operational circuitry including at least memory and a controller, the method comprising:

capturing a cardiac signal using implanted electrodes;

forming a preliminary template;

selecting a fiducial point in the preliminary template;

optimizing the preliminary template; and

verifying the preliminary template if the preliminary template provides a valid representation of a cardiac event or, otherwise, discarding the preliminary template;

wherein the step of optimizing the preliminary template comprises masking a portion of the preliminary template by eliminating portions of the preliminary template that do not apparently contain QRS information of the cardiac signal; and

wherein the step of verifying the preliminary template comprises;

capturing a cardiac signal and identifying a secondary template;

selecting a fiducial point in the secondary template in a manner consistent with the step of selecting a fiducial point in the preliminary template, such that both fiducial points are selected in a similar manner;

optimizing the secondary template in a manner consistent with the step of optimizing the preliminary template; and

comparing the secondary template to the preliminary template to determine whether the two are sufficiently similar to imply that the preliminary template provides a valid representation of a cardiac event.

2. The method of claim 1 wherein:

the preliminary template comprises a predetermined number of sequential digital samples of electrical signals captured using the implanted electrodes;

the step of selecting a fiducial point includes identifying one of the sequential digital samples that represents a peak within the predetermined number of sequential digital samples; and

the step of optimizing the preliminary template includes;

identifying QRS start and end points using monotonic signal analysis;

masking samples outside of the QRS start and end points; and

retaining samples between the QRS start and end point.

3. The method of claim 2 wherein:

the optimized preliminary template comprises the fiducial point and a number of retained digital samples on either side of the fiducial point; and

the step of verifying the preliminary template comprises capturing and configuring a secondary template in accordance with parameters used to optimize the preliminary template.

4. The method of claim 3 wherein the step of configuring the secondary template comprises:

selecting a fiducial point in the secondary template by identifying a peak corresponding to that identified for the fiducial point of the preliminary template; and

retaining a number of samples on either side of the fiducial point corresponding to the number of samples retained on either side of the fiducial point of the preliminary template.

5. The method of claim 1 wherein the implantable medical device is an implantable defibrillator, and the method further comprises comparing the verified preliminary template to sensed cardiac events and, if therapy is indicated by a cardiac rhythm, treating the cardiac rhythm.

6. An implantable medical device comprising:

means for capturing cardiac signals from implanted locations;

means for performing data analysis; and

means for data storage in the implantable medical device;

wherein the means for performing data analysis is configured to perform a method comprising;

sampling a signal captured using the means for capturing;

identifying a peak in the sampled signal as a fiducial point;

configuring a preliminary template using the fiducial point by identifying a number of template samples on either side of the fiducial point, identifying QRS start and end points using monotonic segments on either side of the fiducial point, and masking or discarding portions of the captured cardiac signal falling outside of the identified QRS start and end points;

testing the preliminary template by comparing it to a similarly configured, later captured cardiac signal, with the comparing step leading to verification of the preliminary template or rejection of the preliminary template; and

if the preliminary template is verified, storing the preliminary template using the means for data storage.

7. The implantable medical device of claim 6 wherein the means for performing data analysis is configured such that the step of identifying the QRS start and end points comprises identifying the longest monotonic segments occurring before and after the fiducial point.

8. The implantable medical device of claim 6 wherein the means for capturing cardiac signals from implanted locations comprises a plurality of subcutaneous electrodes.

9. The implantable medical device of claim 6 wherein the means for capturing cardiac signals from implanted locations comprises a plurality of implantable electrodes.

10. A method of characterizing a normal sinus rhythm template in an implantable medical device, the implantable medical device comprising a plurality of implantable electrodes coupled to operational circuitry including at least memory and a controller, the method comprising:

capturing a cardiac signal from implanted electrodes;

identifying one or more peaks within the captured cardiac signal;

selecting one of the one or more peaks within the captured cardiac signal as a fiducial point;

identifying an early monotonic segment occurring prior to the fiducial point;

identifying a late monotonic segment occurring following the fiducial point;

defining a preliminary template as including data captured from approximately the beginning of the early monotonic segment to approximately the end of the late monotonic segment, while excluding at least some portion of the captured cardiac signal from the preliminary template;

establishing a configuration for the preliminary template including a duration from the start of the early monotonic segment to the fiducial point and a duration from the fiducial point to the end of the late monotonic segment;

comparing the preliminary template to a number of similarly configured captured cardiac signals to determine whether the preliminary template accurately characterizes normal cardiac function for the patient; and

;

if so, storing the preliminary template as a Normal Sinus Rhythm template;

or

if not, rejecting the preliminary template.

11. The method of claim 10 wherein the step of capturing a cardiac signal includes:

detecting an event from the captured cardiac signal; and

certifying the detected event as a cardiac signal.

12. The method of claim 11 wherein the cardiac signal comprises a number of signal samples, and wherein the step of defining a preliminary template includes excluding at least some of the signal samples.

13. The method of claim 10 wherein the implanted electrodes are disposed subcutaneously and not in a heart chamber, in or on the heart muscle, or in a patient'"'"'s vasculature.

14. A method of cardiac signal analysis comprising:

performing the method of claim 10 until a Normal Sinus Rhythm Template is stored;

capturing a first cardiac signal from the implanted electrodes;

comparing the first cardiac signal to the Normal Sinus Rhythm Template and;

if the first cardiac signal is similar to the Normal Sinus Rhythm Template, determining that the first cardiac signal indicates normal cardiac function;

or

if the first cardiac signal is not similar the Normal Sinus Rhythm Template, determining that the first cardiac signal does not indicate normal cardiac function.

15. The method of claim 10 wherein the implantable medical device is an implantable defibrillator, and the method further comprises comparing the Normal Sinus Rhythm template to sensed cardiac events and, if therapy is indicated by a cardiac rhythm, treating the cardiac rhythm.

16. A method of establishing a Notched Cardiac Signal Template for a patient having a cardiac rhythm with a QRS complex segment characterized by a notch for use in an implantable cardiac stimulus device comprising a plurality of implantable electrodes coupled to operational circuitry including at least memory and a controller, the notch including first and second peaks separated by a region of lesser amplitude, the method comprising:

determining whether the notch exists by observing whether a captured cardiac preliminary template comprising a plurality of sequential samples of cardiac signal includes first and second peaks that are;

a) separated in amplitude by less than a notch amplitude threshold;

or

b) separated in time by less than a notch time threshold;

if so, identifying a notched signal and establishing the preliminary template as follows;

selecting the first peak as a fiducial point for the preliminary template;

identifying a QRS width using times associated with the starting time of the largest monotonic segment in the preliminary template preceding the fiducial point and the ending time of the largest monotonic segment in the preliminary template that occurs after the fiducial point; and

masking the preliminary template to correspond to the identified QRS width;

then verifying the preliminary template for the notched signal by;

i) capturing at least a detected cardiac event comprising a plurality of sequential samples of cardiac signal;

ii) identifying a fiducial point in the detected cardiac event in the same manner used to identify a fiducial point in the preliminary template;

iii) masking the detected cardiac event around the fiducial point in the same manner used to mask the preliminary template; and

iv) comparing the masked detected cardiac event to the masked preliminary template and;

if the detected cardiac event correlates to the preliminary template, determining that the detected cardiac event suggests verification of the preliminary template;

or

if the detected cardiac event does not correlate to the preliminary template, discarding the preliminary template.

17. The method of claim 16 wherein the step of verifying the preliminary template includes performing steps i)-iv) with up to a predetermined number of detected cardiac events such that:

if analysis of any of the predetermined number of detected cardiac events determines that the preliminary template is not verified, the method includes discarding the preliminary template and identifying a new preliminary template;

or

if analysis of each of the predetermined number of detected cardiac events suggests verification of the preliminary template, the method includes storing the preliminary template as a verified template for use in subsequent cardiac event analysis.

18. The method of claim 16 wherein the implanted electrodes are disposed subcutaneously and not in a heart chamber, in or on the heart muscle, or in a patient'"'"'s vasculature.